GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

AI and Pharma, Future Medicine, Aging & Longevity Corey Hubbafd AI and Pharma, Future Medicine, Aging & Longevity Corey Hubbafd

Decoding the Latest Alzheimer's Setback: Why J&J’s "Failed" Drug Trial is Actually a Hidden Victory for Brain Science

When we think about the fight against Alzheimer’s disease, we often picture a coordinated, unstoppable march toward a cure led by massive organizations like the National Institute on Aging and the Alzheimer's Association.

FDA Compliance, Clinical Trial Operations, Future Medicine, Therapuetics Corey Hubbafd FDA Compliance, Clinical Trial Operations, Future Medicine, Therapuetics Corey Hubbafd

Estrogen Receptor ERβ: A New Hope in the Fight Against Alzheimer’s in Women

If you look at the statistics for Alzheimer’s disease, one striking detail immediately stands out: almost two-thirds of all people living with Alzheimer's are women. For decades, scientists and doctors explained this gap simply by pointing to the calendar—women

Read More
FDA, Therapuetics, Future Medicine, Big Pharma, AI in Healthcare Corey Hubbafd FDA, Therapuetics, Future Medicine, Big Pharma, AI in Healthcare Corey Hubbafd

The Role of AI in Therapeutic Drug Research and Development: Benefits and Challenges

Artificial intelligence (AI) has emerged as a transformative technology across various sectors, and its potential impact on therapeutic drug research and development is significant. By leveraging AI algorithms and machine learning, researchers can potentially accelerate the drug discovery process, identify promising drug candidates, and optimize treatment strategies. However, the integration of AI

Read More
Alzheimer's Research, FDA, Clinical Trials, Future Medicine Corey Hubbafd Alzheimer's Research, FDA, Clinical Trials, Future Medicine Corey Hubbafd

The Hurdles in the Path to Cures: The Unique Challenges of Rare Disease Research

Rare diseases, despite affecting millions of people worldwide, often exist in a shadow cast by more prevalent illnesses. Their rarity presents a unique set of challenges for researchers striving to develop effective treatments and cures. From limited funding to small patient populations, the path to conquering rare diseases is fraught with obstacles.

Read More